{
    "data": [
        {
            "id": "4402583",
            "title": "PJT Partners Non-GAAP EPS of $1.90 beats by $0.77, revenue of $477M beats by $100.88M",
            "description": "<html><body><ul> <li>PJT Partners <a href=\"https://seekingalpha.com/pr/19990109-pjt-partners-inc-reports-full-year-and-fourth-quarter-2024-results\">press release</a> (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/PJT\" title=\"PJT Partners Inc.\">PJT</a></span>): Q4 Non-GAAP EPS of $1.90 <span class=\"green\"> beats by $0.77</span>.</li> <li>Revenue of $477M (+45.0% Y/Y) <span class=\"green\"> beats by $100.88M</span>.</li> <li>Repurchased 3.1 million share and share equivalents through December 31, 2024, with record open market repurchases of 2.2 million shares.</li> <li class=\"paywall-full-content invisible\">Record cash, cash equivalents and short-term investments of $547 million at year-end and no funded debt.</li> <li class=\"paywall-full-content invisible\">The effective tax rate for GAAP Net Income for the years ended December 31, 2024 and 2023 was 11.9% and 18.0%, respectively.</li> </ul> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402583-pjt-partners-non-gaap-eps-of-190-beats-by-077-revenue-of-477m-beats-by-10088m",
            "pub_date": "2025-02-04 14:53:35",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402580",
            "title": "Jacobs approves $1.5B share buyback program",
            "description": "<html><body><ul>\n<li>Jacobs (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/J\" title=\"Jacobs Solutions Inc.\">J</a></span>) said its board has approved a new incremental <a href=\"https://seekingalpha.com/pr/19990097-jacobs-board-approves-1_5-billion-share-repurchase-authorization\" rel=\"noopener\" target=\"_blank\" title=\"share repurchase\">share repurchase</a> authorization.</li>\n<li>The firm is now authorized to buy up to $1.5 billion of its common stock over a three-year period.</li>\n</ul>\n</body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402580-jacobs-approves-1_5b-share-buyback-program",
            "pub_date": "2025-02-04 14:54:03",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402576",
            "title": "Earnings Snapshot: PepsiCo Q4 revenue misses estimates, initiates FY25 soft outlook",
            "description": "<html><body><p><a href=\"https://static.seekingalpha.com/uploads/2025/2/4/saupload_Screenshot_2025-02-04_171830.png\" rel=\"lightbox\" target=\"_blank\"><img src=\"https://static.seekingalpha.com/uploads/2025/2/4/saupload_Screenshot_2025-02-04_171830_thumb1.png\" width=\"100%\"/></a></p>\n</body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402576-earnings-snapshot-pepsico-q4-revenue-misses-estimates-initiates-fy25-soft-outlook",
            "pub_date": "2025-02-04 14:50:08",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402577",
            "title": "Regeneron Pharmaceuticals declares its first-ever dividend of $0.88, announces $3.0B buyback",
            "description": "<html><body><ul>\n<li>Regeneron Pharmaceuticals (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/REGN\" title=\"Regeneron Pharmaceuticals, Inc.\">REGN</a></span>) initiates quarterly dividend of <a href=\"https://seekingalpha.com/pr/19990070-regeneron-reports-fourth-quarter-and-full-year-2024-financial-and-operating-results-initiates\" target=\"_blank\">$0.88/share</a>.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/REGN/dividends/yield?source=news_bullet\">Forward yield</a> 0.53%</li>\n<li>Payable March 20; for shareholders of record Feb. 20; ex-div Feb. 20.</li>\n<li>In February 2025, the Company's board of directors also authorized an additional $3.0 billion share repurchase program, bringing the total current capacity to approximately $4.5 billion.</li>\n<li><a href=\"https://seekingalpha.com/symbol/REGN/dividends?source=news_bullet\">See REGN Dividend Scorecard, Yield Chart, &amp; Dividend Growth.</a></li>\n</ul>\n</body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402577-regeneron-pharmaceuticals-declares-its-first-ever-dividend-of-088-announces-30b-buyback",
            "pub_date": "2025-02-04 14:50:35",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402553",
            "title": "PepsiCo declines after missing organic sales expectations; Coca-Cola and Keurig Dr Pepper also dip",
            "description": "<html><body><p>PepsiCo (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/PEP\" title=\"PepsiCo, Inc.\">PEP</a></span>) traded lower in early action on Tuesday after posting a mixed Q4 earnings report. Organic revenue was up 2.1% for the quarter that ended on December 28 to fall slightly short of the consensus expectation of +2.2%. Organic revenue was down<span class=\"paywall-full-content invisible\"> 2% for the Frito-Lay North America and Quaker Foods North America businesses. </span></p> <p class=\"paywall-full-content invisible\">Volume was 1% higher for both the convenient foods and beverage segments during the quarter and $1.78 a year ago.</p> <p class=\"paywall-full-content invisible\">Operating profit rose 34% in Q4, led by a 323% gain for the Quaker Foods North America business, primarily reflecting the favorable impact of prior-year charges associated with a previously announced voluntary recall of certain bars and cereals in the Quaker Foods North America division (Quaker Recall), a 43-percentage-point impact of an insurance recovery related to the Quaker Recall, productivity savings and lower advertising and marketing expenses, partially offset by certain operating cost increases, a 26-percentage-point impact of impairment charges associated with a nutrition bar brand, a 17-percentage-point impact of higher restructuring charges and a decrease in organic volume.</p> <p class=\"paywall-full-content invisible\">However, operating profit fell for the Frito-Lay North American, PepsiCo Beverages North America, and Latin America businesses. Non-GAAP EPS was reported at $1.96 vs. $1.94 consensus and $1.78 a year ago.</p> <p class=\"paywall-full-content invisible\">\"Our businesses remained resilient in 2024, despite subdued category performance trends inNorth America, the continued impacts related to a recall in our Quaker Foods North Americadivision and business disruptions due to geopolitical tensions in certain international markets.Our enhanced multiyear productivity initiatives enabled us to invest in our businesses, anddeliver improvements in our gross margin, operating margin expansion and EPS in 2024,\" highlighted CEO Ramon Laguarta.</p> <p class=\"paywall-full-content invisible\">Looking ahead, PepsiCo (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/PEP\" title=\"PepsiCo, Inc.\">PEP</a></span>) said it expects to continue to build upon the successfulexpansion of its international business, while also taking actions to improve performance inNorth America. The company expects to deliver low-single-digit organic revenue growth and mid-single-digit core constant currency EPS growth in 2025. PepsiCo (<a href=\"https://seekingalpha.com/symbol/PEP\" title=\"PepsiCo, Inc.\">PEP</a>) also fired off its 53rd consecutive annual increase.</p> <p class=\"paywall-full-content invisible\">Shares of PepsiCo (<a href=\"https://seekingalpha.com/symbol/PEP\" title=\"PepsiCo, Inc.\">PEP</a>) were down <span style=\"color: #ff0000;\">1.34%</span> in premarket trading. Coca-Cola (<a href=\"https://seekingalpha.com/symbol/KO\" title=\"The Coca-Cola Company\">KO</a>) dipped <span style=\"color: #ff0000;\">0.50%</span> and Keurig Dr Pepper (<a href=\"https://seekingalpha.com/symbol/KDP\" title=\"Keurig Dr Pepper Inc.\">KDP</a>) was down <span style=\"color: #ff0000;\">1.04%</span>. Celsius Holdings (<a href=\"https://seekingalpha.com/symbol/CELH\" title=\"Celsius Holdings, Inc.\">CELH</a>) showed a gain of <span style=\"color: #008000;\">0.44%</span>, with PepsiCo's (<a href=\"https://seekingalpha.com/symbol/PEP\" title=\"PepsiCo, Inc.\">PEP</a>) earnings call upcoming.</p> </body></html>",
            "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2161521312/image_2161521312.jpg",
            "link": "https://seekingalpha.com/news/4402553-pepsico-declines-after-missing-organic-sales-expectations-coca-cola-and-keurig-dr-pepper-also-dip",
            "pub_date": "2025-02-04 14:43:48",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402569",
            "title": "MPLX GAAP EPS of $1.07 beats by $0.02, revenue of $3.06B misses by $10M",
            "description": "<html><body><ul> <li>MPLX <a href=\"https://seekingalpha.com/pr/19990093-mplx-lp-progresses-gulf-coast-ngl-strategy-and-reports-full-year-2024-results\">press release</a> (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/MPLX\" title=\"MPLX LP Common Units\">MPLX</a></span>): Q4 GAAP EPS of $1.07 <span class=\"green\"> beats by $0.02</span>.</li> <li>Revenue of $3.06B (+3.0% Y/Y) <span class=\"red\"> misses by $10M</span>.</li> <li>$3.9 billion of capital returned to unitholders in 2024, reflecting 12.5% quarterly distribution increase and $326 million of unit repurchases.</li> <li class=\"paywall-full-content invisible\"><strong>2025 capital spending outlook of $2.0 billion, anticipating mid-teen returns.</strong></li> <li class=\"paywall-full-content invisible\">During the quarter, MPLX generated $1,675 million in net cash provided by operating activities, $1,477 million of distributable cash flow, and adjusted free cash flow of $1,324 million. </li> <li class=\"paywall-full-content invisible\">MPLX announced a fourth-quarter 2024 distribution of $0.9565 per common unit, resulting in distribution coverage of 1.5x for the quarter. </li> <li class=\"paywall-full-content invisible\">The leverage ratio was 3.1x at the end of the quarter.</li> </ul> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402569-mplx-gaap-eps-of-107-beats-by-002-revenue-of-306b-misses-by-10m",
            "pub_date": "2025-02-04 14:44:15",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402564",
            "title": "Aramark reports mixed Q1 results; reaffirms FY25 outlook",
            "description": "<html><body><ul>\n<li>Aramark  <a href=\"https://seekingalpha.com/pr/19990081-aramark-reports-first-quarter-earnings\">press release</a>  (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/ARMK\" title=\"Aramark\">ARMK</a></span>): Q1  Non-GAAP EPS of $0.51 <font color=\"green\"> beats by $0.02</font>.</li>\n<li>Revenue of $4.55B (+3.2% Y/Y) <font color=\"red\"> misses by $60M</font>.</li>\n<li>\n<p>Aramark continues to anticipate its full-year performance for fiscal 2025 as follows:</p>\n<div><table><tbody>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>($ in millions, except EPS)</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>FY24</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"3\" rowspan=\"1\"><p>FY25* Outlook</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>Reference Point</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"3\" rowspan=\"1\"><p>Year-over-year Growth<sup>1</sup></p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Organic Revenue</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$17,401 </p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>+7.5%</p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>—</p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>+9.5%</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Adjusted Operating Income</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$882</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>+15%</p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>—</p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>+18%</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Adjusted EPS</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$1.55 <strong>vs. $1.94 consensus</strong></p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>+23%</p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>—</p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>+28%</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Leverage Ratio</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>3.4x</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"3\" rowspan=\"1\"><p>~3.0x</p></td>\n</tr>\n<tr><td colspan=\"7\" rowspan=\"1\"><p>Adjusted EPS Outlook does not include benefit from potential share repurchases</p></td></tr>\n<tr><td colspan=\"7\" rowspan=\"1\"><p>* 53 week year</p></td></tr>\n<tr><td colspan=\"7\" rowspan=\"1\"><p><sup>1</sup>Constant Currency, except Leverage Ratio</p></td></tr>\n</tbody></table></div>\n</li>\n</ul>\n</body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402564-aramark-reports-mixed-q1-results-reaffirms-fy25-outlook",
            "pub_date": "2025-02-04 14:39:06",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402555",
            "title": "Graphic Packaging Holding raises dividend by 10% to $0.11",
            "description": "<html><body><ul>\n<li>Graphic Packaging Holding (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/GPK\" title=\"Graphic Packaging Holding Company\">GPK</a></span>) declares <a href=\"https://seekingalpha.com/pr/19990063-graphic-packaging-holding-company-announces-10-percent-dividend-increase\" target=\"_blank\">$0.11/share quarterly dividend</a>, <font color=\"green\">10% increase</font> from prior dividend of $0.10.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/GPK/dividends/yield?source=news_bullet\">Forward yield</a> 1.62%</li>\n<li>Payable April 5; for shareholders of record March 15; ex-div March 14.</li>\n<li><a href=\"https://seekingalpha.com/symbol/GPK/dividends?source=news_bullet\">See GPK Dividend Scorecard, Yield Chart, &amp; Dividend Growth.</a></li>\n</ul>\n</body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402555-graphic-packaging-holding-declares-0_11-dividend",
            "pub_date": "2025-02-04 14:39:33",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402560",
            "title": "Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY25 outlook",
            "description": "<html><body><ul> <li>Regeneron Pharmaceuticals <a href=\"https://seekingalpha.com/pr/19990070-regeneron-reports-fourth-quarter-and-full-year-2024-financial-and-operating-results-initiates\">press release</a> (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/REGN\" title=\"Regeneron Pharmaceuticals, Inc.\">REGN</a></span>): Q4 Non-GAAP EPS of $12.07 <span class=\"green\"> beats by $0.88</span>.</li> <li>Revenue of $3.79B (+10.5% Y/Y) <span class=\"green\"> beats by $40M</span>.</li> <li> <em>Fourth quarter 2024 Dupixent</em><sup><em>®</em></sup><em> global net sales</em> <em>(recorded by Sanofi) increased 15% to $3.70 billion versus fourth quarter 2023; full year 2024<span class=\"paywall-full-content invisible\"> Dupixent global net sales increased 22% to $14.15 billion versus 2023.</span></em> </li> <li class=\"paywall-full-content invisible\"> <em>Fourth quarter 2024 U.S. net sales for EYLEA HD</em><sup><em>®</em></sup><em> and EYLEA</em><sup><em>®</em></sup><em> increased 2% versus fourth quarter 2023 to $1.50 billion, including $305 million from EYLEA HD; full year 2024 U.S. net sales for EYLEA HD and EYLEA increased 1% versus 2023 to $5.97 billion versus 2023, including $1.20 billion from EYLEA HD.</em> </li> <li class=\"paywall-full-content invisible\"> <em>Fourth quarter 2024 Libtayo</em><sup><em>®</em></sup><em> global net sales increased 50% to $367 million versus fourth quarter 2023; full year 2024 Libtayo global net sales increased 40% to $1.22 billion versus 2023.</em> </li> <li class=\"paywall-full-content invisible\"><em>Initiation of quarterly cash dividend program, $0.88 dividend declared; additional $3.0 billion share repurchase program authorized, bringing current repurchase capacity to ~$4.5 billion.</em></li> <li class=\"paywall-full-content invisible\"> <p><strong><em>2025 Financial Guidance</em><sup><em>(c)</em></sup></strong></p> <p><strong>The Company's full year 2025 financial guidance consists of the following components:</strong></p> <div><table><tbody> <tr> <td> </td> <td> </td> <td>2025 Guidance</td> </tr> <tr> <td>GAAP R&amp;D</td> <td> </td> <td>$5.560–$5.795 billion</td> </tr> <tr> <td>Non-GAAP R&amp;D<sup>(a)</sup> </td> <td> </td> <td>$5.000–$5.200 billion</td> </tr> <tr> <td>GAAP SG&amp;A</td> <td> </td> <td>$2.910–$3.095 billion</td> </tr> <tr> <td>Non-GAAP SG&amp;A<sup>(a)</sup> </td> <td> </td> <td>$2.550–$2.700 billion</td> </tr> <tr> <td>GAAP gross margin on net product sales<sup>(d)</sup> </td> <td> </td> <td>84%–85%</td> </tr> <tr> <td>Non-GAAP gross margin on net product sales<sup>(a)(d)</sup> </td> <td> </td> <td>87%–88%</td> </tr> <tr> <td>COCM<sup>(e)*</sup> </td> <td> </td> <td>$1.000–$1.150 billion</td> </tr> <tr> <td>Capital expenditures<sup>*</sup> </td> <td> </td> <td>$850–$975 million</td> </tr> <tr> <td>GAAP effective tax rate</td> <td> </td> <td>9%–11%</td> </tr> <tr> <td>Non-GAAP effective tax rate<sup>(a)</sup> </td> <td> </td> <td>11%–13%</td> </tr> <tr> <td> </td> <td> </td> <td> </td> </tr> <tr><td colspan=\"3\">* GAAP and non-GAAP amounts are equivalent as no non-GAAP adjustments have been or are expected to be recorded.</td></tr> <tr><td colspan=\"3\"> </td></tr> </tbody></table></div> <p>A reconciliation of full year 2025 GAAP to non-GAAP financial guidance is included below:</p> <div><table><tbody> <tr> <td> </td> <td> </td> <td colspan=\"7\">Projected Range</td> </tr> <tr> <td><em>($ in millions)</em></td> <td> </td> <td colspan=\"3\">Low</td> <td> </td> <td colspan=\"3\">High</td> </tr> <tr> <td>GAAP R&amp;D</td> <td> </td> <td>$</td> <td>5,560</td> <td> </td> <td> </td> <td>$</td> <td>5,795</td> <td> </td> </tr> <tr> <td>Stock-based compensation expense</td> <td> </td> <td> </td> <td>560</td> <td> </td> <td> </td> <td> </td> <td>590</td> <td> </td> </tr> <tr> <td>Acquisition and integration costs</td> <td> </td> <td> </td> <td>—</td> <td> </td> <td> </td> <td> </td> <td>5</td> <td> </td> </tr> <tr> <td>Non-GAAP R&amp;D</td> <td> </td> <td>$</td> <td>5,000</td> <td> </td> <td> </td> <td>$</td> <td>5,200</td> <td> </td> </tr> <tr> <td> </td> <td> </td> <td colspan=\"3\"> </td> <td> </td> <td colspan=\"3\"> </td> </tr> <tr> <td>GAAP SG&amp;A</td> <td> </td> <td>$</td> <td>2,910</td> <td> </td> <td> </td> <td>$</td> <td>3,095</td> <td> </td> </tr> <tr> <td>Stock-based compensation expense</td> <td> </td> <td> </td> <td>360</td> <td> </td> <td> </td> <td> </td> <td>390</td> <td> </td> </tr> <tr> <td>Acquisition and integration costs</td> <td> </td> <td> </td> <td>—</td> <td> </td> <td> </td> <td> </td> <td>5</td> <td> </td> </tr> <tr> <td>Non-GAAP SG&amp;A</td> <td> </td> <td>$</td> <td>2,550</td> <td> </td> <td> </td> <td>$</td> <td>2,700</td> <td> </td> </tr> <tr> <td> </td> <td> </td> <td colspan=\"3\"> </td> <td> </td> <td colspan=\"3\"> </td> </tr> <tr> <td>GAAP gross margin on net product sales</td> <td> </td> <td> </td> <td>84%</td> <td> </td> <td> </td> <td> </td> <td>85%</td> <td> </td> </tr> <tr> <td>Intangible asset amortization expense</td> <td> </td> <td> </td> <td>2%</td> <td> </td> <td> </td> <td> </td> <td>2%</td> <td> </td> </tr> <tr> <td>Stock-based compensation expense</td> <td> </td> <td> </td> <td>1%</td> <td> </td> <td> </td> <td> </td> <td>1%</td> <td> </td> </tr> <tr> <td>Non-GAAP gross margin on net product sales</td> <td> </td> <td> </td> <td>87%</td> <td> </td> <td> </td> <td> </td> <td>88%</td> <td> </td> </tr> <tr> <td> </td> <td> </td> <td colspan=\"3\"> </td> <td> </td> <td colspan=\"3\"> </td> </tr> <tr> <td>GAAP ETR</td> <td> </td> <td> </td> <td>9%</td> <td> </td> <td> </td> <td> </td> <td>11%</td> <td> </td> </tr> <tr> <td>Income tax effect of GAAP to non-GAAP reconciling items</td> <td> </td> <td> </td> <td>2%</td> <td> </td> <td> </td> <td> </td> <td>2%</td> <td> </td> </tr> <tr> <td>Non-GAAP ETR</td> <td> </td> <td> </td> <td>11%</td> <td> </td> <td> </td> <td> </td> <td>13%</td> <td> </td> </tr> </tbody></table></div> </li> </ul> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402560-regeneron-pharmaceuticals-beats-top-line-and-bottom-line-estimates-initiates-fy25-outlook",
            "pub_date": "2025-02-04 14:33:51",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402561",
            "title": "Graphic Packaging Holding GAAP EPS of $0.46 misses by $0.09, revenue of $2.1B misses by $60M",
            "description": "<html><body><ul> <li>Graphic Packaging Holding <a href=\"https://seekingalpha.com/pr/19990067-graphic-packaging-holding-company-reports-fourth-quarter-and-full-year-2024-results\">press release</a> (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/GPK\" title=\"Graphic Packaging Holding Company\">GPK</a></span>): GAAP EPS of $0.46 <span class=\"red\"> misses by $0.09</span>.</li> <li>Revenue of $2.1B (-6.7% Y/Y) <span class=\"red\"> misses by $60M</span>.</li> <li> The decline was driven primarily by a $103 million negative impact from the divestiture of the Augusta, GA bleached paperboard manufacturing facility and<span class=\"paywall-full-content invisible\"> bleached paperboard price and volume declines, and a $22 million net decline in sales from packaging operations, where price declines were partially offset by volume growth.</span> </li> <li class=\"paywall-full-content invisible\"><p>The Company currently expects 2025 Net Sales, Adjusted EBITDA, and Adjusted EPS, excluding foreign exchange impact, of $8.7 billion to $8.9 billion, $1.68 billion to $1.78 billion, and $2.53 to $2.78, respectively vs $2.69 consensus. At current forward rates, the company estimates current foreign exchange headwinds to Net Sales, Adjusted EBITDA, and Adjusted EPS, of approximately $120 million, $20 million, and $0.05, respectively. Including the current foreign exchange headwind, expected 2025 Net Sales, Adjusted EBITDA, and Adjusted EPS are $8.6 billion to $8.8 billion, $1.66 billion to $1.76 billion, and $2.48 to $2.73, respectively.</p></li> <li class=\"paywall-full-content invisible\"><p>Capital spending is currently expected to be in the range of $700 million as the Company's Waco, Texas recycled paperboard investment moves toward completion.</p></li> </ul> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402561-graphic-packaging-holding-gaap-eps-of-0_46-misses-by-0_09-revenue-of-2_1b-misses-by-60m",
            "pub_date": "2025-02-04 14:35:01",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        }
    ]
}